Top Markets
#1 Pleasing Gold Pleasing Gold +738.04%
#2 Islamic Coin Islamic Coin +154.23%
#3 PulseChain PulseChain +56.20%
#4 BOOK OF MEME BOOK OF MEME +40.59%
#5 DogBull DogBull +37.66%
#6 Collect on Fanable Collect on Fanable +26.22%
#7 Nockchain Nockchain +20.02%
#8 Neiro Neiro +18.83%
#9 rsERG rsERG +17.72%
#10 PondCoin PondCoin +17.19%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
NurExone Biologic Inc. NurExone Biologic Inc.

NurExone Biologic Inc.

NRX
Rank in Stocks #27122
NurExone Biologic Inc., a pharmaceutical technology company, develops a... NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Share Price
$0.47705898
Last synced: 2026-08-19
Market Cap
$35.01M
Change (1 day)
8.33%
Change (1 year)
-16.23%
Country
CA
Trade NurExone Biologic Inc. (NRX)

Category

Healthcare
Dividend history for NurExone Biologic Inc. (NRX)
NurExone Biologic Inc. (stock symbol: NRX) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for NurExone Biologic Inc. (NRX) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH